




Searching News Database: Proteolix
HSMN NewsFeed - 10 Nov 2016
Oncolytics Biotech(R) Inc. Announces Appointment of New Chief Medical Officer
Oncolytics Biotech(R) Inc. Announces Appointment of New Chief Medical Officer
HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
HSMN NewsFeed - 14 Aug 2012
Pharmacyclics(R) Appoints Joshua T. Brumm Executive Vice President of Finance
Pharmacyclics(R) Appoints Joshua T. Brumm Executive Vice President of Finance
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
HSMN NewsFeed - 5 Jan 2011
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 13 May 2010
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations
HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
HSMN NewsFeed - 15 May 2008
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
HSMN NewsFeed - 25 Feb 2008
Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer
Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer